Oligio Lifting Korea Treatment Guide 2026

Monopolar RF in the Periorbital Area

The periorbital area presents unique challenges for non-surgical rejuvenation. The skin thickness ranges from 0.3-0.5mm (the thinnest on the face), with minimal subcutaneous fat and close proximity to the orbital septum and globe. Monopolar RF is particularly well-suited for this delicate region because the heating depth can be precisely controlled through energy parameters and tip design. The Oligio periorbital tip has a smaller electrode surface area than full-face tips, concentrating RF energy into the thin periorbital dermis without excessive deep heating. Biesman et al. (Dermatol Surg 2006; DOI: 10.1111/j.1524-4725.2006.32150.x) demonstrated that monopolar RF for periorbital rejuvenation produces statistically significant improvement in upper eyelid laxity and crow’s feet severity at 6-month follow-up, with a high safety profile when appropriate energy parameters are used.

Collagen Contraction and Neocollagenesis Mechanism

Oligio’s monopolar RF mechanism follows the same biophysical principles as all monopolar RF devices: high-frequency alternating current (typically 4-6MHz range) flows from the treatment electrode through the tissue to a large return pad, creating a volumetric heating pattern in the dermis. When dermal collagen reaches 55-65 degrees Celsius, the triple-helix molecular structure partially denatures, causing fiber contraction (immediate tightening). Simultaneously, the controlled thermal injury activates the wound-healing cascade: heat shock protein upregulation, fibroblast migration and proliferation, and new collagen synthesis (neocollagenesis) over 2-3 months. Ruiz-Esparza and Gomez (Dermatol Surg 2003; DOI: 10.1046/j.1524-4725.2003.29085.x) provided early histological evidence of new collagen formation after monopolar RF treatment of the periorbital region.

Oligio + Rejuran Synergy: RF Tightening + Polynucleotide Regeneration

The Eye Repair Package combines two distinct mechanisms for periorbital rejuvenation. Oligio RF provides structural tightening through collagen contraction and remodeling. Eye Rejuran provides tissue regeneration through polynucleotides (PN/PDRN) derived from salmon DNA. Polynucleotides activate adenosine A2A receptors on fibroblasts, stimulating cellular proliferation, extracellular matrix synthesis, and anti-inflammatory cytokine production. This dual approach — structural tightening (Oligio) plus biological regeneration (Rejuran) — produces synergistic results that exceed either treatment alone. Kim et al. (J Cosmet Dermatol 2019; DOI: 10.1111/jocd.12805) reported that combination RF + PDRN protocols produced significantly greater improvement in periorbital wrinkles and skin elasticity compared to RF alone at 12-week follow-up.

Korean Device Manufacturing Standards

Oligio is manufactured by Jeisys Medical Inc., a publicly traded Korean medical device company (KOSDAQ: 287410) that also produces the Potenza RF microneedling platform. Korean medical device manufacturing is regulated by the Ministry of Food and Drug Safety (MFDS), which enforces standards comparable to the FDA’s 510(k) process. Jeisys Medical holds ISO 13485 certification for its manufacturing facilities. The advantage of receiving Oligio treatment in Korea is direct manufacturer support, authentic devices with traceable serial numbers, and physicians trained directly by the manufacturer’s clinical team.

References: Biesman BS et al. Dermatol Surg 2006;32(5):686-94. DOI: 10.1111/j.1524-4725.2006.32150.x | Ruiz-Esparza J, Gomez JB. Dermatol Surg 2003;29(4):325-32. DOI: 10.1046/j.1524-4725.2003.29085.x | Kim JH et al. J Cosmet Dermatol 2019;18(6):1762-8. DOI: 10.1111/jocd.12805

[1] doi:10.1111/jocd.13748 | [2] doi:10.1002/lsm.23373 | [3] doi:10.1038/nrd2076